PubRank

Ingrid Nygaard

Author PubWeight™ 82.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 2010 7.95
2 Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med 2006 7.42
3 Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002 5.73
4 A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med 2012 4.59
5 Defining success after surgery for pelvic organ prolapse. Obstet Gynecol 2009 3.46
6 Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol 2007 3.16
7 A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med 2012 2.90
8 Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence. Obstet Gynecol 2008 2.58
9 Fecal and urinary incontinence in primiparous women. Obstet Gynecol 2006 2.28
10 Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med 2012 2.03
11 Abdominal pain, bloating, and urgency. Obstet Gynecol 2005 2.02
12 Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol 2005 2.01
13 A randomized trial of colpopexy and urinary reduction efforts (CARE): design and methods. Control Clin Trials 2003 1.93
14 Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 2008 1.85
15 The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol 2009 1.73
16 The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct 2008 1.64
17 Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynecol J 2014 1.61
18 The impact of obesity on urinary incontinence symptoms, severity, urodynamic characteristics and quality of life. J Urol 2009 1.55
19 Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery. J Urol 2011 1.53
20 Flushing and papules in a middle-aged woman. Obstet Gynecol 2005 1.38
21 Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol 2003 1.37
22 Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial--design and methods. Clin Trials 2009 1.24
23 Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn 2011 1.21
24 Pelvic organ support among primiparous women in the first year after childbirth. Int Urogynecol J Pelvic Floor Dysfunct 2009 1.10
25 Comparison of mindfulness-based stress reduction versus yoga on urinary urge incontinence: a randomized pilot study. with 6-month and 1-year follow-up visits. Female Pelvic Med Reconstr Surg 2014 1.05
26 Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial. Contemp Clin Trials 2011 1.04
27 Risk factors for fecal and urinary incontinence after childbirth: the childbirth and pelvic symptoms study. Am J Gastroenterol 2007 1.03
28 Minimum important difference for validated instruments in women with urge incontinence. Neurourol Urodyn 2011 1.01
29 Lower urinary tract symptoms and pelvic floor muscle exercise adherence after 15 years. Obstet Gynecol 2005 1.01
30 Sexual function before and after sacrocolpopexy for pelvic organ prolapse. Am J Obstet Gynecol 2007 0.98
31 Web versus paper-based completion of the epidemiology of prolapse and incontinence questionnaire. Female Pelvic Med Reconstr Surg 2013 0.96
32 Quantification of vaginal support: are continuous summary scores better than POPQ stage? Am J Obstet Gynecol 2010 0.93
33 Childbirth and pelvic floor disorders. Clin Obstet Gynecol 2004 0.93
34 Anorectal dysfunction after surgical treatment for cervical cancer. J Am Coll Surg 2002 0.92
35 Incontinence pessaries: size, POPQ measures, and successful fitting. Int Urogynecol J Pelvic Floor Dysfunct 2009 0.87
36 Enhancing participation of older women in surgical trials. J Am Coll Surg 2008 0.87
37 Muscular fatigue in the pelvic floor muscles after strenuous physical activity. Acta Obstet Gynecol Scand 2007 0.87
38 Long-term follow-up of treatment for synthetic mesh complications. Female Pelvic Med Reconstr Surg 2014 0.86
39 Can women correctly contract their pelvic floor muscles without formal instruction? Female Pelvic Med Reconstr Surg 2013 0.85
40 Sexual function before and after non-surgical treatment for stress urinary incontinence. Female Pelvic Med Reconstr Surg 2011 0.85
41 The minimum important difference for the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form in women with stress urinary incontinence. Neurourol Urodyn 2013 0.85
42 Prevalence, management and impact of urinary incontinence in the workplace. Occup Med (Lond) 2005 0.83
43 Lower urinary tract symptoms, quality of life and pelvic organ prolapse: irritative bladder and obstructive voiding symptoms in women planning to undergo abdominal sacrocolpopexy for advanced pelvic organ prolapse. J Urol 2007 0.82
44 Recovery at home after major gynecologic surgery: how do our patients fare? Obstet Gynecol 2012 0.82
45 Mindfulness-based stress reduction for treatment of urinary urge incontinence: a pilot study. Female Pelvic Med Reconstr Surg 2012 0.81
46 The correlation of voiding variables between non-instrumented uroflowmetery and pressure-flow studies in women with pelvic organ prolapse. Neurourol Urodyn 2008 0.79
47 Changed women: the long-term impact of vaginal mesh complications. Female Pelvic Med Reconstr Surg 2014 0.79
48 Marketed vaginal mesh kits: rampant experimentation or improved quality of care? Thoughts following the 2006 AUGS meeting by AUGS president Ingrid Nygaard, M.D. Int Urogynecol J Pelvic Floor Dysfunct 2007 0.78
49 Do Women Understand Urogynecologic Terminology? Female Pelvic Med Reconstr Surg 2011 0.78
50 Should all women be offered elective cesarean delivery? Obstet Gynecol 2003 0.78
51 Vaginal birth: a relic of the past in bulldogs and women? Obstet Gynecol 2011 0.78
52 What does "FDA Approved" mean for medical devices? Obstet Gynecol 2008 0.77
53 Sexual dysfunction prevalence rates: marketing or real? Obstet Gynecol 2008 0.75
54 The gold standard. Neurourol Urodyn 2009 0.75
55 Surgery for pelvic organ prolapse--reply. JAMA 2013 0.75
56 Cost-Effectiveness Analysis of Anticholinergics Versus Botox for Urgency Urinary Incontinence: Results From the Anticholinergic Versus Botox Comparison Randomized Trial. Female Pelvic Med Reconstr Surg 2016 0.75
57 Urogynecology: the importance of long-term follow-up. Obstet Gynecol 2006 0.75
58 Words and their integral role in scientific research. Obstet Gynecol 2003 0.75
59 Treatment of exercise incontinence with a urethral insert: a pilot study in women. Phys Sportsmed 2002 0.75
60 Jay D. Iams, MD, AJOG Editor. Am J Obstet Gynecol 2016 0.75
61 Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor Disorders. Female Pelvic Med Reconstr Surg 2017 0.75
62 Giants in obstetrics and gynecology. Am J Obstet Gynecol 2016 0.75
63 Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor Disorders. Female Pelvic Med Reconstr Surg 2017 0.75